Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Comparison of PYY, Ghrelin, GLP1, Glucose Level, Level of Satiety, and Ad Libitum Intake in Obese and Non-Obese Patients After Breakfast With Balanced Macronutrient Composition

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03701503
Recruitment Status : Completed
First Posted : October 10, 2018
Last Update Posted : October 10, 2018
Sponsor:
Collaborators:
SEAMEO Regional Centre for Food and Nutrition
Dr Cipto Mangunkusumo General Hospital
Information provided by (Responsible Party):
Fiastuti Witjaksono, Indonesia University

Brief Summary:

Obesity can occur due to an imbalance of energy. This energy balance is greatly influenced by hunger and satiety. Obese person cannot resist hunger, while non obese can control hunger. Gut hormones, such as PYY and ghrelin, are associated with appetite and satiety control. This study's objective is to compare the effect of breakfast with balance composition on gut hormones, glucose and ad libitum intake four hours after breakfast between obese and non obese..

The research methodology was used a clinical trial with 18 obese women and 22 non obese women participants. Subjects were given a balance breakfast (protein 12,4%, carbohydrate 68,2%, fat 22,6%). Gut hormones (PYY, Ghrelin, GLP -1) level , Glucose level and satiety level were measured at 0, 15, 60, 120, and 180 minutes after breakfast. Ad libitum meal was given four hours after breakfast and measured after.


Condition or disease Intervention/treatment Phase
PYY Ghrelin Appetite Gut Hormones Obesity VAS of Satiety VAS of Hunger GLP - 1 Behavioral: Diet with balance composition to know the effect of a meal to gut hormones in obese and non obese women Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 40 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Treatment
Official Title: The Comparison of PYY, Ghrelin, GLP1, Glucose Level, VAS Level of Satiety, VAS Level of Hunger and Ad Libitum Intake in Obese and Non-Obese Patients After Breakfast With Balanced Macronutrient Composition
Actual Study Start Date : October 2010
Actual Primary Completion Date : July 2011
Actual Study Completion Date : July 2011

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Hormones

Arm Intervention/treatment
Experimental: Obese

Women age 20-40, with BMI ≥ 25-35 kg/m2 Given a balanced breakfast (Protein 12,4%, carbohydrate 68,2%, fat 22,6%) with calories according to their energy requirement,which is calculated by adding basal metabolic rate (BMR) with additional energy from physical activity.

Participants' blood was taken before intervention, and 15, 60, 120, and 180 minutes after intervention, then examined in laboratory to measure every outcome. After 4 hours, participants were given ad libitum meal. After the participants done eating, the calorie in meal taken by participants was measured.

Behavioral: Diet with balance composition to know the effect of a meal to gut hormones in obese and non obese women
Active Comparator: Non Obese

Women age 20-40, with BMI 18,5-23 kg/m2 Given a balanced breakfast (Protein 12,4%, carbohydrate 68,2%, fat 22,6%) with calories according to their energy requirement,which is calculated by adding basal metabolic rate (BMR) with additional energy from physical activity.

Participants' blood was taken before intervention, and 15, 60, 120, and 180 minutes after intervention, then examined in laboratory to measure every outcome. After 4 hours, participants were given ad libitum meal. After the participants done eating, the calorie in meal taken by participants was measured.

Behavioral: Diet with balance composition to know the effect of a meal to gut hormones in obese and non obese women



Primary Outcome Measures :
  1. Ghrelin levels at 0 minute [ Time Frame: baseline ]
    analyzed by ELISA, directly taken after having the breakfast with balance composition in both of the study arm.

  2. Ghrelin levels at 15 minute [ Time Frame: 15 minutes ]
    analyzed by ELISA, taken 15 minutes after having the breakfast with balance composition in both of the study arm.

  3. Ghrelin levels at 60 minute [ Time Frame: 60 minutes ]
    analyzed by ELISA, taken 60 minutes after having the breakfast with balance composition in both of the study arm.

  4. Ghrelin levels at 120 minute [ Time Frame: 120 minutes ]
    analyzed by ELISA, taken 120 minutes after having the breakfast with balance composition in both of the study arm

  5. Ghrelin levels at 180 minute [ Time Frame: 180 minutes ]
    analyzed by ELISA, taken 180 minutes after having the breakfast with balance composition in both of the study arm

  6. PYY levels at 0 minute [ Time Frame: baseline ]
    analyzed by Radioimmunoassay, directly taken after having the breakfast with balance composition in both of the study arm

  7. PYY levels at 15 minute [ Time Frame: 15 minutes ]
    analyzed by Radioimmunoassay, taken 15 minutes after having the breakfast with balance composition in both of the study arm

  8. PYY levels at 60 minute [ Time Frame: 60 minutes ]
    analyzed by Radioimmunoassay, taken 60 minutes after having the breakfast with balance composition in both of the study arm

  9. PYY levels at 120 minute [ Time Frame: 120 minutes ]
    analyzed by Radioimmunoassay, taken 120 minutes after having the breakfast with balance composition in both of the study arm

  10. PYY levels at 180 minute [ Time Frame: 180 minutes ]
    analyzed by Radioimmunoassay, taken 180 minutes after having the breakfast with balance composition in both of the study arm

  11. GLP-1 levels at 0 minute [ Time Frame: baseline ]
    analyzed by ELISA, directly taken after having the breakfast with balance composition in both of the study arm

  12. GLP-1 levels at 15 minute [ Time Frame: 15 minutes ]
    analyzed by ELISA, taken 15 minutes after having the breakfast with balance composition in both of the study arm

  13. GLP-1 levels at 60 minute [ Time Frame: 60 minutes ]
    analyzed by ELISA, taken 60 minutes after having the breakfast with balance composition in both of the study arm

  14. GLP-1 levels at 120 minute [ Time Frame: 120 minutes ]
    analyzed by ELISA, taken 120 minutes after having the breakfast with balance composition in both of the study arm

  15. GLP-1 levels at 180 minute [ Time Frame: 180 minutes ]
    analyzed by ELISA, taken 180 minutes after having the breakfast with balance composition in both of the study arm

  16. Glucose levels at 0 minute [ Time Frame: baseline ]
    analyzed by standard random glucose level from venous blood, directly taken after having the breakfast with balanced composition in both of the study arm

  17. Glucose levels at 15 minute [ Time Frame: 15 minutes ]
    analyzed by standard random glucose level from venous blood, taken 15 minutes after having the breakfast with balanced composition in both of the study arm

  18. Glucose levels at 60 minute [ Time Frame: 60 minutes ]
    analyzed by standard random glucose level from venous blood, taken 60 minutes after having the breakfast with balanced composition in both of the study arm

  19. Glucose levels at 120 minute [ Time Frame: 120 minutes ]
    analyzed by standard random glucose level from venous blood, taken 120 minutes after having the breakfast with balanced composition in both of the study arm

  20. Glucose levels at 180 minute [ Time Frame: 180 minutes ]
    analyzed by standard random glucose level from venous blood, taken 180 minutes after having the breakfast with balanced composition in both of the study arm

  21. Ad Libitum intake [ Time Frame: 4 hours ]
    Mean Ad Libitum intake (calories) in subjects four hours after breakfast with balance composition in both of the study arm

  22. VAS for hunger at 0 minutes [ Time Frame: baseline ]
    Visual Analog Scale, a scale in the form of an empty straight line with no values but only several level point (ex: if the line is 10cm, then each cm represent 1 level). Extreme choices are both ends of the straight line. The minimum value is at the left end and the maximum value is at the right end. The subject must make a choice between the two ends of the line by giving an X mark (ex : if the subject feels less hunger, then the subject should mark X at the second point from far left), directly taken after having the breakfast with balance composition in both of the study arm

  23. VAS for hunger at 15 minutes [ Time Frame: 15 minutes ]
    Visual Analog Scale, a scale in the form of an empty straight line with no values but only several level point (ex: if the line is 10cm, then each cm represent 1 level). Extreme choices are both ends of the straight line. The minimum value is at the left end and the maximum value is at the right end. The subject must make a choice between the two ends of the line by giving an X mark (ex : if the subject feels less hunger, then the subject should mark X at the second point from far left), taken 15 minutes after having the breakfast with balance composition in both of the study arm

  24. VAS for hunger at 60 minutes [ Time Frame: 60 minutes ]
    Visual Analog Scale, a scale in the form of an empty straight line with no values but only several level point (ex: if the line is 10cm, then each cm represent 1 level). Extreme choices are both ends of the straight line. The minimum value is at the left end and the maximum value is at the right end. The subject must make a choice between the two ends of the line by giving an X mark (ex : if the subject feels less hunger, then the subject should mark X at the second point from far left), taken 60 minutes after having the breakfast with balance composition in both of the study arm

  25. VAS for hunger at 120 minutes [ Time Frame: 120 minutes ]
    Visual Analog Scale, a scale in the form of an empty straight line with no values but only several level point (ex: if the line is 10cm, then each cm represent 1 level). Extreme choices are both ends of the straight line. The minimum value is at the left end and the maximum value is at the right end. The subject must make a choice between the two ends of the line by giving an X mark (ex : if the subject feels less hunger, then the subject should mark X at the second point from far left), taken 120 minutes after having the breakfast with balance composition in both of the study arm

  26. VAS for hunger at 180 minutes [ Time Frame: 180 minutes ]
    Visual Analog Scale, a scale in the form of an empty straight line with no values but only several level point (ex: if the line is 10cm, then each cm represent 1 level). Extreme choices are both ends of the straight line. The minimum value is at the left end and the maximum value is at the right end. The subject must make a choice between the two ends of the line by giving an X mark (ex : if the subject feels less hunger, then the subject should mark X at the second point from far left), taken 180 minutes after having the breakfast with balance composition in both of the study arm

  27. VAS for satiety at 0 minutes [ Time Frame: baseline ]
    Visual Analog Scale, a scale in the form of an empty straight line with no values but only several level point (ex: if the line is 10cm, then each cm represent 1 level). Extreme choices are both ends of the straight line. The minimum value is at the left end and the maximum value is at the right end. The subject must make a choice between the two ends of the line by giving an X mark (ex : if the subject feels less hunger, then the subject should mark X at the second point from far left), directly taken after having the breakfast with balance composition in both of the study arm

  28. VAS for satiety at 15 minutes [ Time Frame: 15 minutes ]
    Visual Analog Scale, a scale in the form of an empty straight line with no values but only several level point (ex: if the line is 10cm, then each cm represent 1 level). Extreme choices are both ends of the straight line. The minimum value is at the left end and the maximum value is at the right end. The subject must make a choice between the two ends of the line by giving an X mark (ex : if the subject feels less hunger, then the subject should mark X at the second point from far left), taken 15 minutes after having the breakfast with balance composition in both of the study arm

  29. VAS for satiety at 60 minutes [ Time Frame: 60 minutes ]
    Visual Analog Scale, a scale in the form of an empty straight line with no values but only several level point (ex: if the line is 10cm, then each cm represent 1 level). Extreme choices are both ends of the straight line. The minimum value is at the left end and the maximum value is at the right end. The subject must make a choice between the two ends of the line by giving an X mark (ex : if the subject feels less hunger, then the subject should mark X at the second point from far left), taken 60 minutes after having the breakfast with balance composition in both of the study arm

  30. VAS for satiety at 120 minutes [ Time Frame: 120 minutes ]
    Visual Analog Scale, a scale in the form of an empty straight line with no values but only several level point (ex: if the line is 10cm, then each cm represent 1 level). Extreme choices are both ends of the straight line. The minimum value is at the left end and the maximum value is at the right end. The subject must make a choice between the two ends of the line by giving an X mark (ex : if the subject feels less hunger, then the subject should mark X at the second point from far left), taken 120 minutes after having the breakfast with balance composition in both of the study arm

  31. VAS for satiety at 180 minutes [ Time Frame: 180 minutes ]
    Visual Analog Scale, a scale in the form of an empty straight line with no values but only several level point (ex: if the line is 10cm, then each cm represent 1 level). Extreme choices are both ends of the straight line. The minimum value is at the left end and the maximum value is at the right end. The subject must make a choice between the two ends of the line by giving an X mark (ex : if the subject feels less hunger, then the subject should mark X at the second point from far left), taken 180 minutes after having the breakfast with balance composition in both of the study arm



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   20 Years to 40 Years   (Adult)
Sexes Eligible for Study:   Female
Gender Based Eligibility:   Yes
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • BMI 25 - 30 (for obese am)
  • BMI 18,5 - 23 (for NON- obese am)
  • with stable body weight within the last 6 months (body weight change less than 4 kg)
  • normal blood glucose level.

Exclusion Criteria:

  • Patients who never had breakfast
  • patients in weight loss program
  • patients consuming lipid-absorption inhibitor or appetite-suppressing drugs
  • patients that have had gastrointestinal tract resection.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03701503


Locations
Layout table for location information
Indonesia
Departement of Nutrition, Faculty of Medicine Universitas Indonesia
Jakarta, Jakarta Pusat, Indonesia, 10110
Sponsors and Collaborators
Indonesia University
SEAMEO Regional Centre for Food and Nutrition
Dr Cipto Mangunkusumo General Hospital

Layout table for additonal information
Responsible Party: Fiastuti Witjaksono, Principal Investigator, Indonesia University
ClinicalTrials.gov Identifier: NCT03701503     History of Changes
Other Study ID Numbers: GuthormoneOB-NonOB
First Posted: October 10, 2018    Key Record Dates
Last Update Posted: October 10, 2018
Last Verified: October 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Layout table for MeSH terms
Hormones
Nutrients
Hormones, Hormone Substitutes, and Hormone Antagonists
Physiological Effects of Drugs
Growth Substances